Lv4
625 积分 2020-04-20 加入
A phase I study assessing the safety and tolerability of SPL84, an inhaled antisense oligonucleotide for treatment of cystic fibrosis patients with the 3849 +10kb C->T
8天前
已完结
Basic Formulation Semblance and Contemporary Approach of Mini Tablets
2个月前
已关闭
Fixed-Dose Combinations: Innovations, Formulation Strategies, and Regulatory Challenges
2个月前
已关闭
GZR18, a novel long-acting GLP-1 analog, demonstrated positive in vitro and in vivo pharmacokinetic and pharmacodynamic characteristics in animal models
2个月前
已完结
The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects
2个月前
已完结
A literature review of risk assessment approaches in failure mode and effects analysis
2个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
2个月前
已完结
Targeted Oral Peptide Icotrokinra for Psoriasis Involving High-Impact Sites
2个月前
已完结
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents
2个月前
已完结
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
3个月前
已完结
皖公网安备34019202002308
